Table: begin end state 1 20 cytoplasmic 21 41 transmembrane 42 46 non-cytoplasmic 47 64 transmembrane 65 68 cytoplasmic 69 86 transmembrane 87 91 non-cytoplasmic 92 111 transmembrane 112 121 cytoplasmic 122 141 transmembrane 142 152 non-cytoplasmic 153 176 transmembrane 177 182 cytoplasmic 183 201 transmembrane 202 233 non-cytoplasmic 234 254 transmembrane 255 272 cytoplasmic 273 295 transmembrane 296 305 non-cytoplasmic 306 325 transmembrane 326 332 cytoplasmic 333 353 transmembrane 354 364 non-cytoplasmic 365 393 transmembrane 394 495 cytoplasmic
Input: >H281DRAFT_03141 FitnessBrowser__Burk376:H281DRAFT_03141 MNTASPTHGWPARLSGIRANVLAGLTSSFALVPECIAFALVAHLNPLMGLYGAFFICTIT ALFGGRPGMISGAAGSMAVVIVALVVQHGAQYLLATVILSGVLMALFGALRLGKLIRMVP HPVMLGFVNGLAIVIATAQLAHFRQSTPQGEAWLHGSALAMMCGLVALTMLIVYVLPRVT RAAPPALVAIVGVGLFAQLLHLPTRTLGDMAHIAGGLPGFNLPDVPLNLETLQVVLPYAV LIAIVGLLETLLTFNLTDEITETRGQPNRECLALGAANIASGLFGGMGGCAMIGQTMINL NSGGRSRLSGIVSGVMILMYILFLSPLIERIPLAALVGVMFVVAQQTFAWGSLRVLGKVP RNDALVIIAVTLITVFSDLAIAVLCGIVIAALNFAWQHAREIHAHVEDRADNRTYVPRGT LFFASTVRFHELFDPQQDPADVTIDCSHLLLADHSALAALQGLYERYRKAGKQLSVKNLS EHNRRLLSRAGVGLA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server